prednisolone has been researched along with Bone Demineralization, Pathologic in 6 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Bone Demineralization, Pathologic: Decrease, loss, or removal of the mineral constituents of bones. Temporary loss of bone mineral content is especially associated with space flight, weightlessness, and extended immobilization. OSTEOPOROSIS is permanent, includes reduction of total bone mass, and is associated with increased rate of fractures. CALCIFICATION, PHYSIOLOGIC is the process of bone remineralizing. (From Dorland, 27th ed; Stedman, 25th ed; Nicogossian, Space Physiology and Medicine, 2d ed, pp327-33)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To our knowledge, this is the first double-blind randomized study to show that disease-related loss of hand bone density in rheumatoid arthritis can be decelerated by prednisolone." | 9.11 | Reduced loss of hand bone density with prednisolone in early rheumatoid arthritis: results from a randomized placebo-controlled trial. ( Haugeberg, G; Kirwan, JR; Kvien, TK; Strand, A, 2005) |
| "To our knowledge, this is the first double-blind randomized study to show that disease-related loss of hand bone density in rheumatoid arthritis can be decelerated by prednisolone." | 5.11 | Reduced loss of hand bone density with prednisolone in early rheumatoid arthritis: results from a randomized placebo-controlled trial. ( Haugeberg, G; Kirwan, JR; Kvien, TK; Strand, A, 2005) |
| "To observe the influence of prednisolone treatment on bone mineral density (BMD) in children with idiopathic nephrotic syndrome." | 3.75 | Bone mineral density in children with steroid-sensitive nephrotic syndrome. ( Meena, SK; Mishra, OP; Mishra, RN; Prasad, R; Singh, SK, 2009) |
| "Fifteen patients with active Crohn's disease and 19 controls with inactive Crohn's disease were recruited." | 2.71 | Rapid hip bone loss in active Crohn's disease patients receiving short-term corticosteroid therapy. ( Greenwood, R; Probert, CS; Sasi, MR; Tobias, JH, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mishra, OP | 1 |
| Meena, SK | 1 |
| Singh, SK | 1 |
| Prasad, R | 1 |
| Mishra, RN | 1 |
| Tobias, JH | 1 |
| Sasi, MR | 1 |
| Greenwood, R | 1 |
| Probert, CS | 1 |
| Haugeberg, G | 2 |
| Strand, A | 1 |
| Kvien, TK | 1 |
| Kirwan, JR | 1 |
| Skingle, SJ | 1 |
| Moore, DJ | 1 |
| Crisp, AJ | 1 |
| Kipen, Y | 1 |
| Briganti, E | 1 |
| Strauss, B | 1 |
| Will, R | 1 |
| Littlejohn, G | 1 |
| Morand, E | 1 |
| Vetvik, K | 1 |
| Stallemo, A | 1 |
| Bitter, H | 1 |
| Mikkelsen, B | 1 |
| Stokkeland, M | 1 |
3 trials available for prednisolone and Bone Demineralization, Pathologic
| Article | Year |
|---|---|
Rapid hip bone loss in active Crohn's disease patients receiving short-term corticosteroid therapy.
Topics: Adult; Age of Onset; Bone Demineralization, Pathologic; Bone Density; Crohn Disease; Female; Femur N | 2004 |
Reduced loss of hand bone density with prednisolone in early rheumatoid arthritis: results from a randomized placebo-controlled trial.
Topics: Adult; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Bone Demineralization, | 2005 |
Cyclical etidronate increases lumbar spine bone density in patients on long-term glucocorticosteroid therapy.
Topics: Adult; Aged; Aged, 80 and over; Bone Demineralization, Pathologic; Bone Density; Chronic Disease; Et | 1997 |
3 other studies available for prednisolone and Bone Demineralization, Pathologic
| Article | Year |
|---|---|
Bone mineral density in children with steroid-sensitive nephrotic syndrome.
Topics: Absorptiometry, Photon; Anti-Inflammatory Agents; Bone Demineralization, Pathologic; Bone Density; C | 2009 |
Three year followup of bone mineral density change in premenopausal women with systemic lupus erythematosus.
Topics: Absorptiometry, Photon; Adult; Body Mass Index; Bone Demineralization, Pathologic; Bone Density; Dem | 1999 |
Bone density reduction in patients with Crohn disease and associations with demographic and disease variables: cross-sectional data from a population-based study.
Topics: Absorptiometry, Photon; Adult; Age Distribution; Age Factors; Aged; Anti-Inflammatory Agents; Body W | 2001 |